pharma brand strategy Archives - Pharma Marketing Network

Home Tags Pharma brand strategy

Pharmaceutical commercial leadership team discussing a global pharma commercialization strategy in a corporate meeting.

One Commercial Leader, Fewer Silos: Daiichi Sankyo’s Reorg Raises a Bigger...

Donna Pacheco - August 27, 2026

Global pharmaceutical pricing dominoes illustrate how MFN drug pricing in international markets could influence US drug prices and launch strategy.

The Global Pricing Domino Effect: Could One Market Reshape Your US...

Donna Pacheco - August 19, 2026

Primary care physician discussing treatment options with a patient while digital healthcare and patient identification icons illustrate modern primary care pharma marketing.

From Mechanism to Minutes: How Pharma Brands Win Over Primary Care

Donna Pacheco - June 26, 2026

Scientist analyzing biomarker data and DNA diagnostics in a modern laboratory, illustrating biomarker diagnostic marketing and precision medicine strategies in the pharmaceutical industry.

Marketing the Biomarker Before the Brand: Pharma’s New Growth Strategy

Donna Pacheco - June 23, 2026

Healthcare professional experiencing information overload from digital alerts, clinical content, EHR notifications, and administrative demands in a modern healthcare setting.

The Clinical Attention Crisis: Why Pharma Must Earn Every Second of...

Donna Pacheco - June 16, 2026

Business leaders and healthcare decision-makers reviewing employee health benefits and healthcare strategy data in a corporate meeting environment.

The Stakeholder Pharma Keeps Missing: Why Employers Matter More Than Ever

Donna Pacheco - June 9, 2026

Advanced healthcare network centered around a specialty treatment center, illustrating how Centers of Excellence influence regional patient referrals, provider collaboration, and specialty pharma market development.

Why the Most Important Specialty Pharma Markets Aren’t Always the Biggest...

Donna Pacheco - June 8, 2026

Doctor facing prior authorization barriers and prescribing friction inside an electronic health record system

The Frictionless Script: Why “Covered” Drugs Still Fail at the Point...

Donna Pacheco - May 19, 2026

Pharmaceutical communications team monitoring market sentiment and FDA advisory vote outcomes during a critical 48-hour response window.

The 48-Hour Window: What Happens After an FDA Advisory Vote Can...

Donna Pacheco - May 19, 2026

Advisory Committees as Brand Moments: Preparing for Public Scientific Scrutiny

Donna Pacheco - May 12, 2026

12 Page 1 of 2